Title : NCOA4-RET fusion in colorectal cancer: Therapeutic challenge using patient-derived tumor cell lines.

Pub. Date : 2018

PMID : 30210625






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In colon cancer PDCs with NCOA4-RET fusion, vandetanib potently inhibited AKT and ERK phosphorylation. vandetanib mitogen-activated protein kinase 1 Homo sapiens